BOLD
Price
$1.08
Change
-$0.01 (-0.92%)
Updated
Dec 3 closing price
Capitalization
24.18M
Intraday BUY SELL Signals
OSTX
Price
$1.75
Change
+$0.09 (+5.42%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
60.22M
Intraday BUY SELL Signals
Interact to see
Advertisement

BOLD vs OSTX

Header iconBOLD vs OSTX Comparison
Open Charts BOLD vs OSTXBanner chart's image
Boundless Bio
Price$1.08
Change-$0.01 (-0.92%)
Volume$150.2K
Capitalization24.18M
OS Therapies
Price$1.75
Change+$0.09 (+5.42%)
Volume$470
Capitalization60.22M
BOLD vs OSTX Comparison Chart in %
BOLD
Daily Signal:
Gain/Loss:
OSTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BOLD vs. OSTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and OSTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BOLD: $1.08 vs. OSTX: $1.66)
Brand notoriety: BOLD and OSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 61% vs. OSTX: 34%
Market capitalization -- BOLD: $24.4M vs. OSTX: $60.22M
BOLD [@Biotechnology] is valued at $24.4M. OSTX’s [@Biotechnology] market capitalization is $60.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileOSTX’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • OSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLD is a better buy in the long-term than OSTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 3 TA indicator(s) are bullish while OSTX’s TA Score has 3 bullish TA indicator(s).

  • BOLD’s TA Score: 3 bullish, 6 bearish.
  • OSTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, OSTX is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а -2.70% price change this week, while OSTX (@Biotechnology) price change was -7.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OSTX($60.2M) has a higher market cap than BOLD($24.2M). OSTX (-61.145) and BOLD (-62.759) have similar YTD gains . OSTX has higher annual earnings (EBITDA): -13.72M vs. BOLD (-70.2M). BOLD has more cash in the bank: 127M vs. OSTX (2.8M). OSTX has less debt than BOLD: OSTX (16.7M) vs BOLD (49.5M). BOLD (0) and OSTX (0) have equivalent revenues.
BOLDOSTXBOLD / OSTX
Capitalization24.2M60.2M40%
EBITDA-70.2M-13.72M512%
Gain YTD-62.759-61.145103%
P/E Ratio0.16N/A-
Revenue00-
Total Cash127M2.8M4,532%
Total Debt49.5M16.7M296%
TECHNICAL ANALYSIS
Technical Analysis
BOLDOSTX
RSI
ODDS (%)
Bullish Trend 7 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
68%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 7 days ago
88%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signal:
Gain/Loss:
OSTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BONXF0.12N/A
N/A
Bonterra Resources Inc.
CCARF1.50N/A
N/A
Colonial Coal International Corp
EBCOF15.53N/A
N/A
Ebara Corp.
IWTNF11.73N/A
N/A
IWATANI CORP.
BMYMP840.00N/A
N/A
Bristol-Myers Squibb Co.

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with RCKT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-0.92%
RCKT - BOLD
40%
Loosely correlated
-2.06%
VYGR - BOLD
37%
Loosely correlated
-4.89%
DSGN - BOLD
36%
Loosely correlated
+0.11%
RGNX - BOLD
36%
Loosely correlated
-3.10%
ZNTL - BOLD
36%
Loosely correlated
-1.82%
More

OSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OSTX has been loosely correlated with CADL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OSTX jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSTX
1D Price
Change %
OSTX100%
-2.75%
CADL - OSTX
36%
Loosely correlated
-1.56%
RPTX - OSTX
34%
Loosely correlated
-0.14%
MRKR - OSTX
31%
Poorly correlated
+0.85%
PVLA - OSTX
28%
Poorly correlated
-3.19%
BOLD - OSTX
26%
Poorly correlated
-0.92%
More